Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 450 participants.

Also called NCT05051033

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 450 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05051033
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, Germany, Spain, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05051033. Randomized; no masking; primary purpose treatment. Start 2022-02-21 (actual); primary completion 2029-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
Acronym
PRIMARY
Condition
Mitral Valve Regurgitation
Intervention (Procedure)
Mitral valve repair
Intervention (Device)
Transcatheter edge-to-edge repair
Lead sponsor
Annetine Gelijns (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05051033
Content hash
f9cc220be1c2e91eb26ab0923e42388a0a1265a9f42a0809f8757af1e79c1fc0